Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA).
Suresh Kotagal,
Beth Malow,
Karen Spruyt,
Guanghai Wang,
Carlos Ernest Bolaños Almeida
et al.
Other
Sleep medicine
2024
24 件の引用
研究デザイン
- 研究タイプ
- narrative review / clinical guidance
- 対象集団
- Children with autism spectrum disorder and other neurogenetic disorders with insomnia
- 介入
- Melatonin use in managing insomnia in children with autism and other neurogenetic disorders - An assessment by the international pediatric sleep association (IPSA). varies
- 比較対照
- placebo or standard care
- 主要アウトカム
- sleep onset, sleep quality in autism/neurogenetic disorder children
- 効果の方向
- Positive
- バイアスリスク
- Unclear
抄録
Though it is widely prescribed for improving sleep of children with autism and other neurogenetic disorders, there is a need for practical guidance to clinicians on the use of melatonin for managing insomnia in this population. Because data were either lacking or inconclusive, a task force was established by the International Pediatric Sleep Association (IPSA) to examine the literature based on clinical trials from 2012 onwards. A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith.
要約
A summary of evidence pertaining to melatonin's utility and potential side effects, practice-related caveats, and insights for use are published herewith.